Literature DB >> 2229265

Determination of the plasma protein binding of the coumarin anticoagulants phenprocoumon and its metabolites, warfarin and acenocoumarol, by ultrafiltration and high-performance liquid chromatography.

J X de Vries1, U Völker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2229265     DOI： 10.1016/s0378-4347(00)83858-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  7 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Authors:  Francesco Scaglione
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

Review 3.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.

Authors:  Mike Ufer; Jan O Svensson; Kristopher W Krausz; Harry V Gelboin; Anders Rane; Gunnel Tybring
Journal:  Eur J Clin Pharmacol       Date:  2004-03-31       Impact factor: 2.953

5.  Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease.

Authors:  Reinhild Klein
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

6.  Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model.

Authors:  Khaled Abduljalil; Simone Lazar; Michael Natanzon; Weidong Wu; Gregor Zadoyan; Benedict Steffens; Victoria Kohl; Klaus Mörike; Dorota Tomalik-Scharte; Julia Stingl; Matthias Schwab; Job Harenberg; Christoph Gleiter; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

7.  Development of a Fluorescent Microfluidic Device Based on Antibody Microarray Read-Out for Therapeutic Drug Monitoring of Acenocoumarol.

Authors:  J-Pablo Salvador; Thomas Brettschneider; Christian Dorrer; M-Pilar Marco
Journal:  Front Bioeng Biotechnol       Date:  2022-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.